Germinal Center Response to mRNA Vaccination and Impact of Immunological Imprinting on Subsequent Vaccination

키워드

참고문헌 (92)

1. Lan J, "Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor", Nature, 581, pp.215~220 (2020)
2. Barouch DH, "COVID-19 vaccines-immunity, variants, boosters", N Engl J Med, 387, pp.1011~1020 (2022)
3. Dashdorj NJ, "Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia", Cell Host Microbe, 29, pp.1738~1743 (2021)
4. Zhang Z, "Humoral and cellular immune memory to four COVID-19 vaccines", Cell, 185, pp.2434~2451 (2022)
5. Baden LR, "Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine", N Engl J Med, 384, pp.403~416 (2021)
6. Polack FP, "Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine", N Engl J Med, 383, pp.2603~2615 (2020)
7. Slifka MK, "How advances in immunology provide insight into improving vaccine efficacy", Vaccine, 32, pp.2948~2957 (2014)
8. Mesin L, "Germinal center B cell dynamics", Immunity, 45, pp.471~482 (2016)
9. Berek C, "Maturation of the immune response in germinal centers", Cell, 67, pp.1121~1129 (1991)
10. Cyster JG, "B cell follicles and antigen encounters of the third kind", Nat Immunol, 11, pp.989~996 (2010)
11. Carati C, "Anatomy and physiology in relation to compression of the upper limb and thorax", J Lymphoedema, 5, pp.58~67 (2010)
12. Havenar-Daughton C, "Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations", J Immunol Methods, 479, pp.112746~ (2020)
13. Lederer K, "Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals", Cell, 185, pp.1008~1024 (2022)
14. Mudd PA, "SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans", Cell, 185, pp.603~613 (2022)
15. Röltgen K, "Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination", Cell, 185, pp.1025~1040 (2022)
16. Kim W, "Germinal centre-driven maturation of B cell response to mRNA vaccination", Nature, 604, pp.141~145 (2022)
17. Turner JS, "SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses", Nature, 596, pp.109~113 (2021)
18. Cyster JG, "B cell responses : cell interaction dynamics and decisions", Cell, 177, pp.524~540 (2019)
19. Young C, "The unique biology of germinal center B cells", Immunity, 54, pp.1652~1664 (2021)
20. Phan TG, "High affinity germinal center B cells are actively selected into the plasma cell compartment", J Exp Med, 203, pp.2419~2424 (2006)
21. Kräutler NJ, "Differentiation of germinal center B cells into plasma cells is initiated by high-affinity antigen and completed by Tfh cells", J Exp Med, 214, pp.1259~1267 (2017)
22. Hammarlund E, "Plasma cell survival in the absence of B cell memory", Nat Commun, 8, pp.1781~ (2017)
23. Zehentmeier S, "Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cells", Eur J Immunol, 44, pp.2306~2317 (2014)
24. Brynjolfsson SF, "Long-lived plasma cells in human bone marrow can be either CD19+ or CD19", Blood Adv, 1, pp.835~838 (2017)
25. Mesin L, "Restricted clonality and limited germinal center reentry characterize memory b cell reactivation by boosting", Cell, 180, pp.92~106 (2020)
26. Turner JS, "Human germinal centres engage memory and naive B cells after influenza vaccination", Nature, 586, pp.127~132 (2020)
27. Ng KW, "Preexisting and de novo humoral immunity to SARS-CoV-2 in humans", Science, 370, pp.1339~1343 (2020)
28. Murray SM, "The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses", Nat Rev Immunol, 23, pp.304~316 (2023)
29. Purtha WE, "Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants", J Exp Med, 208, pp.2599~2606 (2011)
30. Pape KA, "Different B cell populations mediate early and late memory during an endogenous immune response", Science, 331, pp.1203~1207 (2011)
31. Elsner RA, "Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity", Immunity, 53, pp.1136~1150 (2020)
32. Alsoussi WB, "SARS-CoV-2 Omicron boosting induces de novo B cell response in humans", Nature, 617, pp.592~598 (2023)
33. Wrammert J, "Rapid cloning of high-affinity human monoclonal antibodies against influenza virus", Nature, 453, pp.667~671 (2008)
34. Ellebedy AH, "Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination", Nat Immunol, 17, pp.1226~1234 (2016)
35. Kardava L, "Early human B cell signatures of the primary antibody response to mRNA vaccination", Proc Natl Acad Sci U S A, 119, pp.e2204607119~ (2022)
36. Bok K, "Accelerated COVID-19 vaccine development : milestones, lessons, and prospects", Immunity, 54, pp.1636~1651 (2021)
37. Jung J, "Comparison of waning immunity between booster vaccination and 2-dose vaccination with BNT162b2", Immune Netw, 22, pp.e31~ (2022)
38. Laidlaw BJ, "The germinal centre B cell response to SARS-CoV-2", Nat Rev Immunol, 22, pp.7~18 (2022)
39. Sette A, "Adaptive immunity to SARS-CoV-2 and COVID-19", Cell, 184, pp.861~880 (2021)
40. Krause PR, "SARS-CoV-2 variants and vaccines", N Engl J Med, 385, pp.179~186 (2021)
41. Victora GD, "Germinal centers", Annu Rev Immunol, 30, pp.429~457 (2012)
42. Alameh MG, "Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses", Immunity, 54, pp.2877~2892 (2021)
43. Li C, "Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine", Nat Immunol, 23, pp.543~555 (2022)
44. Tahtinen S, "IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines", Nat Immunol, 23, pp.532~542 (2022)
45. Hassett KJ, "mRNA vaccine trafficking and resulting protein expression after intramuscular administration", Mol Ther Nucleic Acids, 35, pp.102083~ (2023)
46. Martínez-Riaño A, "Long-term retention of antigens in germinal centers is controlled by the spatial organization of the follicular dendritic cell network", Nat Immunol, 24, pp.1281~1294 (2023)
47. Pikor NB, "Remodeling of light and dark zone follicular dendritic cells governs germinal center responses", Nat Immunol, 21, pp.649~659 (2020)
48. Cho A, "Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination", Nature, 600, pp.517~522 (2021)
49. Sokal A, "mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants", Immunity, 54, pp.2893~2907 (2021)
50. Goel RR, "mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern", Science, 374, pp.abm0829~ (2021)
51. Pape KA, "High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines", Cell Reports, 37, pp.109823~ (2021)
52. Tong P, "Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike", Cell, 184, pp.4969~4980 (2021)
53. Sterlin D, "IgA dominates the early neutralizing antibody response to SARS-CoV-2", Sci Transl Med, 13, pp.eabd2223~ (2021)
54. Corthésy B, "Multi-faceted functions of secretory IgA at mucosal surfaces", Front Immunol, 4, pp.185~ (2013)
55. Wang Z, "Enhanced SARS-CoV-2 neutralization by dimeric IgA", Sci Transl Med, 13, pp.eabf1555~ (2021)
56. Sheikh-Mohamed S, "Guardians of the oral and nasopharyngeal galaxy : IgA and protection against SARS-CoV-2 infection", Immunol Rev, 309, pp.75~85 (2022)
57. Hassan AO, "A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2", Cell, 183, pp.169~184 (2020)
58. Carr EJ, "SARS-CoV-2 mucosal neutralising immunity after vaccination", Lancet Infect Dis, 24, pp.e4~e5 (2024)
59. McMahan K, "Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques", Nature, 626, pp.385~391 (2024)
60. Waltz E, "How nasal-spray vaccines could change the pandemic", Nature, 609, pp.240~242 (2022)
61. Moore KA, "A research and development(R&D)roadmap for broadly protective coronavirus vaccines : a pandemic preparedness strategy", Vaccine, 41, pp.2101~2112 (2023)
62. Becerra X, "Project NextGen-defeating SARS-CoV-2 and preparing for the next pandemic", N Engl J Med, 389, pp.773~775 (2023)
63. Wang Z, "mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants", Nature, 592, pp.616~622 (2021)
64. Andrews N, "COVID-19 vaccine effectiveness against the Omicron(B. 1. 1. 529)variant", N Engl J Med, 386, pp.1532~1546 (2022)
65. Kuhlmann C, "Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose", Lancet, 399, pp.625~626 (2022)
66. Schmidt F, "Plasma neutralization of the SARS-CoV-2 Omicron variant", N Engl J Med, 386, pp.599~601 (2022)
67. Cele S, "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization", Nature, 602, pp.654~656 (2022)
68. Francis T, "On the doctrine of original antigenic sin", Proc Am Philos Soc, 104, pp.572~578 (1960)
69. Henry C, "From original antigenic sin to the universal influenza virus vaccine", Trends Immunol, 39, pp.70~79 (2018)
70. Koutsakos M, "Immunological imprinting : understanding COVID-19", Immunity, 56, pp.909~913 (2023)
71. Cobey S, "Immune history and influenza virus susceptibility", Curr Opin Virol, 22, pp.105~111 (2017)
72. Good KL, "Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells", J Immunol, 182, pp.890~901 (2009)
73. Lucas C, "Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity", Nature, 600, pp.523~529 (2021)
74. Muecksch F, "Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost", Nature, 607, pp.128~134 (2022)
75. Goel RR, "Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine", Cell, 185, pp.1875~1887 (2022)
76. Arunachalam PS, "Durability of immune responses to mRNA booster vaccination against COVID-19", J Clin Invest, 133, pp.e167955~ (2023)
77. Choi A, "Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults : an interim analysis", Nat Med, 27, pp.2025~2031 (2021)
78. Zhang NN, "Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant", Cell Res, 32, pp.401~403 (2022)
79. Scheaffer SM, "Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA. 5 Omicron variant in mice", Nat Med, 29, pp.247~257 (2023)
80. Collier AY, "Immunogenicity of BA. 5 bivalent mRNA vaccine boosters", N Engl J Med, 388, pp.565~567 (2023)
81. Nham E, "Low neutralizing activities to the omicron subvariants BN. 1 and XBB. 1. 5 of sera from the individuals vaccinated with a BA. 4", 5-containing bivalent mRNA vaccine, 2023, pp.23, e43~
82. Chu L, "Immune response to SARS-CoV-2 after a booster of mRNA-1273 : an open-label phase 2 trial", Nat Med, 28, pp.1042~1049 (2022)
83. Schiepers A, "Molecular fate-mapping of serum antibody responses to repeat immunization", Nature, 615, pp.482~489 (2023)
84. Smith DJ, "Variable efficacy of repeated annual influenza vaccination", Proc Natl Acad Sci U S A, 96, pp.14001~14006 (1999)
85. Huang CQ, "Immune imprinting and next-generation coronavirus vaccines", Nat Microbiol, 8, pp.1971~1985 (2023)
86. Addetia A, "Neutralization, effector function and immune imprinting of Omicron variants", Nature, 621, pp.592~601 (2023)
87. Hoffmann M, "Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation", Lancet Infect Dis, 23, pp.25~28 (2023)
88. Tortorici MA, "Persistent immune imprinting occurs after vaccination with the COVID-19 XBB. 1. 5 mRNA booster in humans", Immunity, 57, pp.904~911 (2024)
89. Chalkias S, "Original SARS-CoV-2 monovalent and Omicron BA. 4", BA. 5 bivalent COVID-19 mRNA vaccines : phase 2, Nat Med, pp.2023, 29[DOI]
90. Chalkias S, "A bivalent omicron-containing booster vaccine against COVID-19", N Engl J Med, 387, pp.1279~1291 (2022)
91. "Statement on the antigen composition of COVID-19 vaccines"[URL]
92. Yisimayi A, "Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting", Nature, 625, pp.148~156 (2024)

관련 논문AI추천